City-Wide Medical Grand Rounds: Organoids as potential vehicles for precision medicine
May 16, 2018
Organoids as potential vehicles for precision medicine
David Andrews, PhD
Director and Senior Scientist, Biological Sciences, Sunnybrook Research Institute
Professor, Departments of Biochemistry and Medical Biophysics, University of Toronto
Canada Research Chair in Membrane Biogenesis
At the end of the presentation, participants should be able to:
- Recognize the concept of conditional reprogramming and how this differs from induced pluripotency.
- Describe what an organoid is and how organoids can be used to study human physiology.
- Summarize the use of organoids in drug development applications.
- Predict the utility of organoids in clinical trials, diagnosis and treatment decisions.
- University Health Network – Toronto General Hospital
Medical Education, Eaton Ground 025/026
- Markham Stouffville
- Michael Garron
Gray Steele conference room
- Sinai Health
Mount Sinai Hospital: 18th floor auditorium
- St. Michael’s
LKSKI: Keenan Research Centre auditorium - 2nd fl.
Bayview: McLaughlin Lecture Theatre, EG 61
St. John's Rehab: S3 332
- Trillium Health Partners
Credit Valley: ADMIN Meeting Room #1 (4F119)
Mississauga: Enbridge Room
- University Health Network
Toronto Western: Main auditorium, 2W 401
- West Park
- Women's College
Questions will be accepted via email at firstname.lastname@example.org and Twitter.
Evaluation & Attendance
Attendance for Maintenance of Certification credit will only be tracked if the evaluation and attendance surveys are completed.